Waters Parkerson & Co’s iShares Biotechnology ETF IBB Stock Holding History

Waters Parkerson & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$704K	Hold	3,700	–	–	0.03%	122
2026 Q1	$625K	Hold	3,700	–	–	0.03%	121
2025 Q4	$624K	Hold	3,700	–	–	0.03%	126
2025 Q3	$534K	Hold	3,700	–	–	0.03%	129
2025 Q2	$468K	Sell	3,700 -150	-4%	-$18.4K	0.02%	137
2025 Q1	$492K	Buy	3,850 +150	+4%	+$20.3K	0.03%	135
2024 Q4	$489K	Hold	3,700	–	–	0.03%	135
2024 Q3	$539K	Hold	3,700	–	–	0.03%	129
2024 Q2	$508K	Buy	3,700 +1,300	+54%	+$174K	0.03%	122
2024 Q1	$329K	Hold	2,400	–	–	0.02%	147
2023 Q4	$326K	Hold	2,400	–	–	0.02%	146
2023 Q3	$293K	Hold	2,400	–	–	0.02%	144
2023 Q2	$305K	Hold	2,400	–	–	0.02%	145
2023 Q1	$310K	Hold	2,400	–	–	0.02%	141
2022 Q4	$315K	Hold	2,400	–	–	0.02%	145
2022 Q3	$281K	Hold	2,400	–	–	0.02%	144
2022 Q2	$282K	Hold	2,400	–	–	0.02%	142
2022 Q1	$313K	Hold	2,400	–	–	0.02%	144
2021 Q4	$366K	Hold	2,400	–	–	0.02%	144
2021 Q3	$388K	Hold	2,400	–	–	0.02%	140
2021 Q2	$393K	Hold	2,400	–	–	0.02%	139
2021 Q1	$361K	Hold	2,400	–	–	0.02%	142
2020 Q4	$364K	Hold	2,400	–	–	0.02%	137
2020 Q3	$325K	Hold	2,400	–	–	0.02%	132
2020 Q2	$328K	Hold	2,400	–	–	0.03%	127
2020 Q1	$259K	Hold	2,400	–	–	0.03%	132
2019 Q4	$289K	Sell	2,400 -111	-4%	-$12.4K	0.02%	136
2019 Q3	$250K	Hold	2,511	–	–	0.02%	142
2019 Q2	$274K	Hold	2,511	–	–	0.02%	139
2019 Q1	$281K	Hold	2,511	–	–	0.02%	135
2018 Q4	$242K	Hold	2,511	–	–	0.02%	141
2018 Q3	$306K	Hold	2,511	–	–	0.03%	131
2018 Q2	$276K	Hold	2,511	–	–	0.02%	135
2018 Q1	$268K	Buy	2,511 +111	+5%	+$12.3K	0.02%	141
2017 Q4	$256K	Hold	2,400	–	–	0.02%	154
2017 Q3	$267K	Hold	2,400	–	–	0.02%	147
2017 Q2	$248K	Hold	2,400	–	–	0.02%	149
2017 Q1	$235K	Hold	2,400	–	–	0.02%	148
2016 Q4	$212K	Hold	2,400	–	–	0.02%	158
2016 Q3	$232K	Hold	2,400	–	–	0.02%	142
2016 Q2	$206K	Hold	2,400	–	–	0.02%	144
2016 Q1	$209K	Hold	2,400	–	–	0.02%	133
2015 Q4	$271K	Hold	2,400	–	–	0.03%	129
2015 Q3	$243K	Hold	2,400	–	–	0.03%	118
2015 Q2	$295K	Hold	2,400	–	–	0.03%	116
2015 Q1	$275K	Hold	2,400	–	–	0.03%	121
2014 Q4	$243K	Hold	2,400	–	–	0.03%	124
2014 Q3	$219K	Hold	2,400	–	–	0.03%	128
2014 Q2	$206K	Buy	+2,400	New	+$189K	0.02%	132
2014 Q1	–	Sell	-2,895	Closed	-$219K	–	141
2013 Q4	$219K	Buy	+2,895	New	+$205K	0.03%	129

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

Waters Parkerson & Co's IBB Position: Q2 2026 in Review

Waters Parkerson & Co held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 3,700 shares worth $704K. The position accounts for 0.03% of the portfolio, ranked #122.

Waters Parkerson & Co first reported a position in IBB in Q4 2013 and has held it in 50 quarters since. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Waters Parkerson & Co held 3,700 shares of iShares Biotechnology ETF worth $704K as of Q2 2026.
Waters Parkerson & Co left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.03% of Waters Parkerson & Co's portfolio in Q2 2026, its #122 holding.
Waters Parkerson & Co first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 50 quarters since.
601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.